Citation
Hsu, Jui, et al. "Performance Characteristics of Selected Immunoassays for Preliminary Test of 3,4-methylenedioxymethamphetamine, Methamphetamine, and Related Drugs in Urine Specimens." Journal of Analytical Toxicology, vol. 27, no. 7, 2003, pp. 471-8.
Hsu J, Liu C, Liu CP, et al. Performance characteristics of selected immunoassays for preliminary test of 3,4-methylenedioxymethamphetamine, methamphetamine, and related drugs in urine specimens. J Anal Toxicol. 2003;27(7):471-8.
Hsu, J., Liu, C., Liu, C. P., Tsay, W. I., Li, J. H., Lin, D. L., & Liu, R. H. (2003). Performance characteristics of selected immunoassays for preliminary test of 3,4-methylenedioxymethamphetamine, methamphetamine, and related drugs in urine specimens. Journal of Analytical Toxicology, 27(7), 471-8.
Hsu J, et al. Performance Characteristics of Selected Immunoassays for Preliminary Test of 3,4-methylenedioxymethamphetamine, Methamphetamine, and Related Drugs in Urine Specimens. J Anal Toxicol. 2003;27(7):471-8. PubMed PMID: 14607002.
TY - JOUR
T1 - Performance characteristics of selected immunoassays for preliminary test of 3,4-methylenedioxymethamphetamine, methamphetamine, and related drugs in urine specimens.
AU - Hsu,Jui,
AU - Liu,Chiareiy,
AU - Liu,C P,
AU - Tsay,Wen-Ing,
AU - Li,Jih-Heng,
AU - Lin,Dong-Liang,
AU - Liu,Ray H,
PY - 2003/11/11/pubmed
PY - 2004/7/17/medline
PY - 2003/11/11/entrez
SP - 471
EP - 8
JF - Journal of analytical toxicology
JO - J Anal Toxicol
VL - 27
IS - 7
N2 - Eight commercially available immunoassays for amphetamines (DRI Amphetamines, CEDIA DAU Amphetamines-Semiquantitative, EMIT d.a.u. Monoclonal Amphetamine/Methamphetamine, Synchron CX Systems AMPH, TDx/TDxFLx Amphetamine/Methamphetamine II, CEDIA Amphetamines/Ecstasy, COBAS INTEGRA Amphetamines, and Abuscreen((R)) OnLine HS Amphetamine/MDMA) are evaluated for their effectiveness in serving as the preliminary test methodology for the analysis of 3,4-methylenedioxymethamphetamine/3,4-methylenedioxyamphetamine (MDMA/MDA) and methamphetamine/amphetamine (MA/AM). Standard solutions (in urine matrix) of MDMA, MDA, MA, and AM are used to determine these immunoassays' reactivities (or cross-reactivities) toward these compounds of interest. Case specimens containing MDMA/MDA and MA/AM are also used to study the correlations of the apparent immunoassay MDMA (or MA) concentrations and the gas chromatographic-mass spectrometric concentrations of these compounds. Data resulting from this study suggest that CEDIA Amphetamines/Ecstasy can best predict the concentrations of MDMA and MA in case specimens and can also detect the presence of MDMA at low levels, whereas Abuscreen OnLine HS Amphetamine/MDMA can detect both MDMA and MA at low concentrations.
SN - 0146-4760
UR - https://www.unboundmedicine.com/medline/citation/14607002/Performance_characteristics_of_selected_immunoassays_for_preliminary_test_of_34_methylenedioxymethamphetamine_methamphetamine_and_related_drugs_in_urine_specimens_
L2 - https://academic.oup.com/jat/article-lookup/doi/10.1093/jat/27.7.471
DB - PRIME
DP - Unbound Medicine
ER -